New Market Research Report: Central America Pharmaceuticals & Healthcare Report Q3 2014
Panama and Costa Rica will continue to outperform in comparison with other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize. Improving healthcare investment present revenue-generating opportunities for multinational pharmaceutical companies. Generic drugmakers can also benefit from the widespread uptake of generic drugs in the region and its efficient purchasing platforms, such as COMISCA.
View full press release